317 related articles for article (PubMed ID: 19195672)
1. Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques.
Pal R; Nuttall J; Galmin L; Weiss D; Chung HK; Romano J
Virology; 2009 Mar; 386(1):102-8. PubMed ID: 19195672
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
[TBL] [Abstract][Full Text] [Related]
3. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
[TBL] [Abstract][Full Text] [Related]
4. Generation of a dual RT Env SHIV that is infectious in rhesus macaques.
Smith JM; Dauner A; Li B; Srinivasan P; Mitchell J; Hendry M; Ellenberger D; Butera S; Otten RA
J Med Primatol; 2010 Aug; 39(4):213-23. PubMed ID: 20618587
[TBL] [Abstract][Full Text] [Related]
5. Virological and molecular characterization of a simian human immunodeficiency virus (SHIV) encoding the envelope and reverse transcriptase genes from HIV-1.
Pal R; Galmin L; Pereira LE; Li B; Zhang J; Li D; Francis J; McNicholl JM; Weiss DE; Smith JM
Virology; 2012 Oct; 432(1):173-83. PubMed ID: 22769870
[TBL] [Abstract][Full Text] [Related]
6. Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques.
Stolte-Leeb N; Loddo R; Antimisiaris S; Schultheiss T; Sauermann U; Franz M; Mourtas S; Parsy C; Storer R; La Colla P; Stahl-Hennig C
AIDS Res Hum Retroviruses; 2011 Sep; 27(9):933-43. PubMed ID: 21332419
[TBL] [Abstract][Full Text] [Related]
7. Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques.
Harouse JM; Tan RC; Gettie A; Dailey P; Marx PA; Luciw PA; Cheng-Mayer C
Virology; 1998 Aug; 248(1):95-107. PubMed ID: 9705259
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of a real-time RT-PCR to detect plasma viral load of simian/human immunodeficiency virus CN97001 during its in vivo passage in rhesus monkeys].
Liu Q; Li J; Yang GB; Xing H; Dai JJ; Shao YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):174-6. PubMed ID: 17653328
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of a new simian/human immunodeficiency viruses clone carrying an env gene derived from a CRF07_BC strain.
Li Y; Yang GB; Chen QM; Liu Q; Meng ZF; Geng YQ; Qiao WT; Shao YM
Chin Med J (Engl); 2009 Dec; 122(23):2874-9. PubMed ID: 20092794
[TBL] [Abstract][Full Text] [Related]
10. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
[TBL] [Abstract][Full Text] [Related]
11. A simian-human immunodeficiency virus carrying the rt gene from Chinese CRF01_AE strain of HIV is sensitive to nucleoside reverse transcriptase inhibitors and has a highly genetic stability in vivo.
Wang W; Yao N; Ju B; Dong Z; Cong Z; Jiang H; Qin C; Wei Q
Microbes Infect; 2014 Jun; 16(6):461-71. PubMed ID: 24709063
[TBL] [Abstract][Full Text] [Related]
12. Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.
Hofman MJ; Higgins J; Matthews TB; Pedersen NC; Tan C; Schinazi RF; North TW
Antimicrob Agents Chemother; 2004 Sep; 48(9):3483-90. PubMed ID: 15328115
[TBL] [Abstract][Full Text] [Related]
13. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
[TBL] [Abstract][Full Text] [Related]
14. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
Subbarao S; Otten RA; Ramos A; Kim C; Jackson E; Monsour M; Adams DR; Bashirian S; Johnson J; Soriano V; Rendon A; Hudgens MG; Butera S; Janssen R; Paxton L; Greenberg AE; Folks TM
J Infect Dis; 2006 Oct; 194(7):904-11. PubMed ID: 16960777
[TBL] [Abstract][Full Text] [Related]
15. Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.
North TW; Van Rompay KK; Higgins J; Matthews TB; Wadford DA; Pedersen NC; Schinazi RF
J Virol; 2005 Jun; 79(12):7349-54. PubMed ID: 15919889
[TBL] [Abstract][Full Text] [Related]
16. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
[TBL] [Abstract][Full Text] [Related]
17. Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.
Van Rompay KK; Johnson JA; Blackwood EJ; Singh RP; Lipscomb J; Matthews TB; Marthas ML; Pedersen NC; Bischofberger N; Heneine W; North TW
Retrovirology; 2007 Apr; 4():25. PubMed ID: 17417971
[TBL] [Abstract][Full Text] [Related]
18. A spatio-temporal assessment of simian/human immunodeficiency virus (SHIV) evolution reveals a highly dynamic process within the host.
Feder AF; Kline C; Polacino P; Cottrell M; Kashuba ADM; Keele BF; Hu SL; Petrov DA; Pennings PS; Ambrose Z
PLoS Pathog; 2017 May; 13(5):e1006358. PubMed ID: 28542550
[TBL] [Abstract][Full Text] [Related]
19. Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques.
Smith MS; Foresman L; Lopez GJ; Tsay J; Wodarz D; Lifson JD; Page A; Wang C; Li Z; Adany I; Buch S; Bischofberger N; Narayan O
Virology; 2000 Nov; 277(2):306-15. PubMed ID: 11080478
[TBL] [Abstract][Full Text] [Related]
20. Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates.
Otten RA; Adams DR; Kim CN; Jackson E; Pullium JK; Lee K; Grohskopf LA; Monsour M; Butera S; Folks TM
J Infect Dis; 2005 Jan; 191(2):164-73. PubMed ID: 15609225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
